Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Heymach

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerDavid J Stewart, Maria I Nunez, Carmen Behrens, et al.
Oncotarget|June 27, 2013
Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I populationJennifer Wheler, Gerald Falchook, Apostolia M Tsimberidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538Jeffrey Bogart, Xiaofei Wang, Gregory Masters, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2026
Brief Report: Mature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: CALGB 30610 (Alliance) / RTOG 0538Jeffrey A Bogart, Xiaofei Wang, Gregory Masters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapyErick Riquelme, Milind Suraokar, Carmen Behrens, et al.
Arxiv|September 5, 2025
The Next Layer: Augmenting Foundation Models with Structure-Preserving and Attention-Guided Learning for Local Patches to Global Context Awareness in Computational PathologyMuhammad Waqas, Rukhmini Bandyopadhyay, Eman Showkatian, et al.
Oncogene|December 12, 2018
LCE: an open web portal to explore gene expression and clinical associations in lung cancerLing Cai, ShinYi Lin, Luc Girard, et al.
Nature Machine Intelligence|November 29, 2021
Radiological tumor classification across imaging modality and histologyJia Wu, Chao Li, Michael Gensheimer, et al.
Oncogene|September 11, 2019
Correction: LCE: an open web portal to explore gene expression and clinical associations in lung cancerLing Cai, ShinYi Lin, Luc Girard, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerDavid J Stewart, Maria I Nunez, Carmen Behrens, et al.
Oncotarget|June 27, 2013
Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I populationJennifer Wheler, Gerald Falchook, Apostolia M Tsimberidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538Jeffrey Bogart, Xiaofei Wang, Gregory Masters, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2026
Brief Report: Mature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: CALGB 30610 (Alliance) / RTOG 0538Jeffrey A Bogart, Xiaofei Wang, Gregory Masters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapyErick Riquelme, Milind Suraokar, Carmen Behrens, et al.
Arxiv|September 5, 2025
The Next Layer: Augmenting Foundation Models with Structure-Preserving and Attention-Guided Learning for Local Patches to Global Context Awareness in Computational PathologyMuhammad Waqas, Rukhmini Bandyopadhyay, Eman Showkatian, et al.
Oncogene|December 12, 2018
LCE: an open web portal to explore gene expression and clinical associations in lung cancerLing Cai, ShinYi Lin, Luc Girard, et al.
Nature Machine Intelligence|November 29, 2021
Radiological tumor classification across imaging modality and histologyJia Wu, Chao Li, Michael Gensheimer, et al.
Oncogene|September 11, 2019
Correction: LCE: an open web portal to explore gene expression and clinical associations in lung cancerLing Cai, ShinYi Lin, Luc Girard, et al.
Pageof 8